Premium
FOXP1 EXPRESSION IS INVERSELY CORRELATED WITH EZH2 MUTATION STATUS AND PREDICTS POOR FAILURE‐FREE SURVIVAL IN FOLLICULAR LYMPHOMA TREATED WITH RITUXIMAB AND CHEMOTHERAPY
Author(s) -
Mottok A.,
Jurinovic V.,
Farinha P.,
Rosenwald A.,
Ott G.,
Klapper W.,
Boesl M.,
Hiddemann W.,
Steidl C.,
Connors J.M.,
Sehn L.H.,
Gascoyne R.D.,
Hoster E.,
Weigert O.,
Kridel R.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2437_23
Subject(s) - medicine , oncology , cohort , follicular lymphoma , rituximab , tissue microarray , proportional hazards model , diffuse large b cell lymphoma , progression free survival , chop , lymphoma , immunohistochemistry , chemotherapy